Skip to content

The effect of the milk drink on immunity index for healthy adults

The effect of the milk drink on immunity index for healthy adults: A double-blind, randomized, controlled parallel group study - The effect of the milk drink on immunity index for healthy adults: A double-blind, randomized, controlled parallel group study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049778
Enrollment
100
Registered
2022-12-20
Start date
2022-12-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Fermented milk drink 1 bottle/day for 42 days Unfermented milk drink 1 bottle/day for 42 days

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Males and Females aged 20 to 59 years when informed consent. 2. Subjects who work as company employees or part-time workers within office buildings at least once a week. 3. Subjects who receive enough explain of the test, who deeply understanding of the test, and who obtain own consent to participate the test.

Exclusion criteria

Exclusion criteria: subjects -- 1. proved positive for COVID-19 before the pre-test, hepatitis B, hepatitis C, syphilis, or acquired immune deficiency syndrome at the pre-test, 2. with positive for COVID-19 within the past four weeks before the final examination, 3. planning to be vaccinated against COVID-19 and influenza, during this test, 4. having any symptoms (e.g., chronic rhinitis, asthma), with a difficulty in distinguishing from upper respiratory tract infection, 5. with any difficulty in giving up taking pollinosis medicines (except eye and nasal drops) during this test, 6. with abdominal symptoms by ingesting dairy products, 7. who constantly intake fermented dairy products and/or lactic acid bacteria preparation (e.g., yogurt, lactic fermenting beverage), 8. who take steadily (over twice a week) in affecting health-specific/functional/supplementary/health foods, 9. who take steadily (over twice a week) in affecting medicines (e.g., antibiotic/gut/laxative regulation), 10. with excessive alcohol intake, 11. with heavy heavy smoking (more than 21per day), 12. with extremely irregular eating habits / life rhythm (e.g., midnight work), 13. who have previous and/or current medical history of serious disease, 14. with pregnant, possibly pregnant, or lactating, 15. who have previous medical history of drug and/or food, allergy, especially for milk, 16. being under other clinical tests, or partook in those within the past four weeks before this test, or will join those after the consent, 17. who donated over 0.2L blood and/or blood components within the last one month. 18. who donated over his 0.4L whole blood within the last three month, 19. who donated over her 0.4L whole blood within the last four month, 20. being collected in total of his blood (1.2 L) within the past 12 months and in this test, 21. being collected in total of her blood (0.8 L) within the past 12 months and in this test, 22. Others who have been determined ineligible by principal investigator --.

Design outcomes

Primary

MeasureTime frame
Immunity index

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company Limited Clinical Planning Department

cpcc-contact@cpcc.co.jp03-6225-9001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026